Loulis Food Ingredients S.A. (KYLO.AT)
EUR 3.56
(1.71%)
EUR 3.56
(1.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 19.85 Million EUR | 8.12% |
| 2022 | 10.07 Million EUR | 64.05% |
| 2021 | 4.69 Million EUR | -18.34% |
| 2020 | 6.51 Million EUR | 71.07% |
| 2019 | 8.21 Million EUR | 12.08% |
| 2018 | 6.41 Million EUR | -14.56% |
| 2017 | 9.45 Million EUR | -44.48% |
| 2016 | 11.19 Million EUR | 77.22% |
| 2015 | 5.95 Million EUR | -8.41% |
| 2014 | 6.47 Million EUR | 21.25% |
| 2013 | 5.33 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.98 Million EUR | -43.66% |
| 2024 Q2 | 3.98 Million EUR | 0.0% |
| 2023 Q1 | 1.81 Million EUR | -38.27% |
| 2023 FY | - EUR | 8.12% |
| 2023 Q4 | 6.18 Million EUR | 0.0% |
| 2023 Q2 | 4.01 Million EUR | 121.3% |
| 2022 Q1 | 2.52 Million EUR | 28.05% |
| 2022 Q4 | 2.93 Million EUR | 124.97% |
| 2022 Q2 | 5.05 Million EUR | 100.0% |
| 2022 FY | - EUR | 64.05% |
| 2022 Q3 | 1.3 Million EUR | -74.2% |
| 2021 Q4 | 1.97 Million EUR | 102.11% |
| 2021 Q2 | 2.71 Million EUR | 98.5% |
| 2021 FY | - EUR | -18.34% |
| 2021 Q1 | 1.36 Million EUR | -47.58% |
| 2021 Q3 | 977.19 Thousand EUR | -64.01% |
| 2020 Q3 | 1.29 Million EUR | -67.05% |
| 2020 Q4 | 2.6 Million EUR | 101.69% |
| 2020 FY | - EUR | 71.07% |
| 2020 Q1 | 1.96 Million EUR | -58.61% |
| 2020 Q2 | 3.92 Million EUR | 100.0% |
| 2019 Q3 | 2.37 Million EUR | -31.78% |
| 2019 FY | - EUR | 12.08% |
| 2019 Q1 | 1.73 Million EUR | -7.78% |
| 2019 Q2 | 3.47 Million EUR | 100.0% |
| 2019 Q4 | 4.74 Million EUR | 100.0% |
| 2018 Q1 | 1.32 Million EUR | -29.02% |
| 2018 Q4 | 1.88 Million EUR | 0.0% |
| 2018 FY | - EUR | -14.56% |
| 2018 Q2 | 1.32 Million EUR | 0.0% |
| 2018 Q3 | 1.88 Million EUR | 42.5% |
| 2017 Q2 | 1.51 Million EUR | 0.0% |
| 2017 Q1 | 1.51 Million EUR | -49.71% |
| 2017 Q4 | 1.86 Million EUR | 0.0% |
| 2017 FY | - EUR | -44.48% |
| 2017 Q3 | 1.86 Million EUR | 23.03% |
| 2016 FY | - EUR | 77.22% |
| 2016 Q3 | 3.01 Million EUR | 35.49% |
| 2016 Q4 | 3.01 Million EUR | 0.0% |
| 2016 Q2 | 2.22 Million EUR | 0.0% |
| 2016 Q1 | 2.22 Million EUR | 25.96% |
| 2015 Q1 | 1.97 Million EUR | -9.62% |
| 2015 Q2 | 717.93 Thousand EUR | -63.57% |
| 2015 Q3 | 1.44 Million EUR | 101.82% |
| 2015 FY | - EUR | -8.41% |
| 2015 Q4 | 1.76 Million EUR | 21.79% |
| 2014 Q4 | 2.18 Million EUR | 39.27% |
| 2014 Q1 | 1.57 Million EUR | 1.81% |
| 2014 Q2 | 1.14 Million EUR | -27.21% |
| 2014 Q3 | 1.56 Million EUR | 36.31% |
| 2014 FY | - EUR | 21.25% |
| 2013 Q2 | 1.14 Million EUR | -28.26% |
| 2013 FY | - EUR | 0.0% |
| 2013 Q4 | 1.55 Million EUR | 48.1% |
| 2013 Q3 | 1.04 Million EUR | -8.61% |
| 2013 Q1 | 1.59 Million EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Evrofarma SA | 5.31 Million EUR | -273.771% |
| Flour Mills Kepenos S.A. | 3.64 Million EUR | -444.423% |
| Kri-Kri Milk Industry S.A. | 45.96 Million EUR | 56.801% |